We are live on ! Find out more
EP

Elkfork Partners Portfolio holdings

AUM $4.11B
1-Year Est. Return 5.26%
This Fund
S&P 500
This Quarter Est. Return
-13.25%
1 Year Est. Return
+5.26%
3 Year Est. Return
+52.4%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$3.55B
AUM Growth
-$661M
Cap. Flow
-$52.1M
Cap. Flow %
-1.47%
Top 10 Hldgs %
24.55%
Holding
1,098
New
85
Increased
374
Reduced
258
Closed
83

Top Buys

Rank Stock Value
1
CI icon
Cigna
CI
+$32.1M
2
COP icon
ConocoPhillips
COP
+$17.9M
3
LIN icon
Linde
LIN
+$17.1M
4
XOM icon
ExxonMobil
XOM
+$15.1M
5
FTNT icon
Fortinet
FTNT
+$11.1M

Top Sells

Rank Stock Value
1
ESRX
Express Scripts Holding Company
ESRX
+$51.2M
2
PX
Praxair Inc
PX
+$24.6M
3
SLB icon
SLB Ltd
SLB
+$16.4M
4
HUM icon
Humana
HUM
+$10.3M
5
CELG
Celgene Corp
CELG
+$9.53M

Sector Composition

Rank Sector Weight
1 Technology 18.48%
2 Financials 15.73%
3 Healthcare 13.18%
4 Consumer Discretionary 13.17%
5 Industrials 10.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AYX
976
DELISTED
Alteryx Inc
AYX
$23K ﹤0.01%
+392
New +$21.3K
CHRS icon
977
Coherus Oncology
CHRS
$217M
$20K ﹤0.01%
+2,176
New +$25.2K
QTWO icon
978
Q2 Holdings
QTWO
$3.8B
$20K ﹤0.01%
+408
New +$20.8K
DNLI icon
979
Denali Therapeutics
DNLI
$3.65B
$19K ﹤0.01%
+918
New +$16.7K
SNDX icon
980
Syndax Pharmaceuticals
SNDX
$1.69B
$19K ﹤0.01%
+4,284
New +$23.5K
SRPT icon
981
Sarepta Therapeutics
SRPT
$1.57B
$19K ﹤0.01%
+176
New +$22K
TWST icon
982
Twist Bioscience
TWST
$5.7B
$19K ﹤0.01%
+814
New +$18K
NEWR
983
DELISTED
New Relic, Inc.
NEWR
$19K ﹤0.01%
+238
New +$20K
COUP
984
DELISTED
Coupa Software Incorporated
COUP
$19K ﹤0.01%
+308
New +$19.5K
TWLO icon
985
Twilio
TWLO
$30B
$18K ﹤0.01%
+198
New +$16.1K
VRNT
986
DELISTED
Verint Systems
VRNT
$18K ﹤0.01%
+824
New +$18.9K
PRTK
987
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$18K ﹤0.01%
+3,536
New +$26.8K
OBSV
988
DELISTED
ObsEva SA Ordinary Shares
OBSV
$18K ﹤0.01%
1,386
-1,232
-47% -$18.3K
NUAN
989
DELISTED
Nuance Communications, Inc.
NUAN
$18K ﹤0.01%
+1,617
New +$22.7K
DOMO icon
990
Domo
DOMO
$174M
$16K ﹤0.01%
+836
New +$14.8K
ICL icon
991
ICL Group
ICL
$6.53B
$16K ﹤0.01%
+2,750
New +$16.3K
ARNA
992
DELISTED
Arena Pharmaceuticals Inc
ARNA
$16K ﹤0.01%
+408
New +$16K
AIMT
993
DELISTED
Aimmune Therapeutics
AIMT
$16K ﹤0.01%
+660
New +$17.1K
ALTR
994
DELISTED
Altair Engineering Inc
ALTR
$15K ﹤0.01%
+532
New +$17.5K
SSTI icon
995
SoundThinking
SSTI
$100M
$14K ﹤0.01%
+448
New +$16.7K
ECOM
996
DELISTED
CHANNELADVISOR CORPORATION
ECOM
$14K ﹤0.01%
+1,232
New +$13.8K
TRQ
997
DELISTED
Turquoise Hill Resources Ltd
TRQ
$14K ﹤0.01%
799
-46
-5% -$829
SNNA
998
DELISTED
Sienna Biopharmaceuticals, Inc.
SNNA
$14K ﹤0.01%
6,048
-17,668
-74% -$156K
BOX icon
999
Box
BOX
$4.37B
$13K ﹤0.01%
+792
New +$14.6K
DOCU
1000
DocuSign
DOCU
$10.5B
$13K ﹤0.01%
+330
New +$13.9K
38 39
40
41 42

Similar funds

GHCM
Glen Harbor Capital Management San Diego, California $4.82B AUM 4.69% 1-Year Est. Return
FCM
Flinton Capital Management Philadelphia, Pennsylvania $3.22B AUM 4.75% 1-Year Est. Return
NA
Neuburgh Advisers Los Angeles, California $3.22B AUM 3.74% 1-Year Est. Return
FIM
Foresters Investment Management New York $5.05B AUM 5.06% 1-Year Est. Return
MCIM
Meadow Creek Investment Management Atlanta, Georgia $5.09B AUM 5.82% 1-Year Est. Return
TAM
Tyers Asset Management Austin, Texas $3.02B AUM 5.29% 1-Year Est. Return
TAM
Tiverton Asset Management Wilimington, Delaware $2.88B AUM 5.6% 1-Year Est. Return
RCM
Riverhead Capital Management Wilmington, Delaware $2.71B AUM 2.34% 1-Year Est. Return

Elkfork Partners's Q4 2018 Portfolio in Review

As of Q4 2018, Elkfork Partners held 1,098 positions worth $3.55B, down 16% from $4.21B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Elkfork Partners's Q4 2018 filing shows 85 new, 374 increased, 258 reduced and 83 closed positions. Its largest new stake was Linde: 108,108 shares worth $16.9M. The largest sale was Express Scripts Holding Company, an estimated $51.2M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 18% a quarter earlier, followed by Financials and Healthcare.

  • Elkfork Partners's largest Q4 2018 buy was Linde: 108,108 shares worth $16.9M.
  • Elkfork Partners added most to Cigna in Q4 2018, an estimated $32.1M increase.
  • Elkfork Partners's biggest Q4 2018 reduction was SLB Ltd, cutting an estimated $16.4M.
  • Elkfork Partners fully exited Express Scripts Holding Company in Q4 2018, selling an estimated $51.2M.
  • Elkfork Partners's ten largest holdings make up 25% of its $3.55B portfolio in Q4 2018.
  • Elkfork Partners opened 85 new positions and closed 83 in Q4 2018.
  • Elkfork Partners's portfolio value fell 16% quarter-over-quarter to $3.55B.

Based on Elkfork Partners's 13F filing for Q4 2018, filed 13 Feb 2019.